Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort

Axelle Mabo1, Raphael Borie2, Lidwine Wemeau-Stervinou3

  • 1Service de Pneumologie, Centre de Compétence pour les Maladies Pulmonaires Rares, Hôpital Pontchaillou, CHU Rennes, Rennes, France.

Thorax
|September 27, 2023
PubMed
Abstract

Insights

Autoimmune pulmonary alveolar proteinosis (aPAP) patients frequently experience infections, particularly opportunistic ones like nocardiosis. Early detection of slow-growing bacteria is crucial for managing these infections in aPAP patients.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Rare Diseases

Background:

  • Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare condition.
  • aPAP increases the risk of infections, but a comprehensive understanding is lacking.

Purpose of the Study:

  • To characterize infections and clinical outcomes in aPAP patients.
  • To identify risk factors for opportunistic infections in aPAP.

Main Methods:

  • Retrospective cohort study of 104 aPAP patients (2008-2018) in France and Belgium.
  • Data collected via standardized questionnaire: demographics, comorbidities, imaging, outcomes, microbiology.

Main Results:

  • 58% of patients developed infections; 22% had opportunistic infections, mainly Nocardia (10 cases).
  • Male gender was linked to opportunistic infections (OR=3.88).
  • Higher anti-GM-CSF antibody titers correlated with nocardiosis.

Conclusions:

  • aPAP patients are prone to opportunistic infections, especially Nocardia.
  • Systematic screening for slow-growing bacteria in lavage fluid is recommended for aPAP patients.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
314
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
262
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
253
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
327
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
256